The 6th Conference of the International Stomach Cancer Club (HIGCF 2026) takes place from May 13-16, at FV Hospital and University Medical Center Hospital in Ho Chi Minh City. The program gathers more than 500 experts from around the world, aiming to update trends in minimally invasive treatment, multi-modal treatment and new technology applications in digestive surgery.
On May 13 and 14, four demonstration surgeries were performed at FV Hospital, including two cases of full stomach removal using da Vinci Xi robot, one case of endoscopic partial stomach removal and one case of early treatment of stomach injury by endoscopy. The surgeries were directly connected to the hall to serve training and professional exchange.
In particular, the robot surgery on May 13 was performed for a 51-year-old female patient with stomach cancer. The major surgery lasted more than 7 hours with the cooperation of leading world experts.
Prof. Dr. Ichiro Uyama - Head of Department of Endoscopic Surgery and Robotics, Fujita Medical University, an expert who has performed more than 1,000 surgeries thanks to the da Vinci Xi robot system to treat stomach and esophageal cancer, assesses that da Vinci Xi robot brings many advantages in complex cases thanks to its ability to observe 3D clearly and operate flexibly in difficult surgical areas.
According to Assoc. Prof. Dr. Vo Duy Long - Deputy Head of the Department of Gastrointestinal Surgery, University Medical Center Hospital HCMC, robotic surgery is opening up a new approach in the treatment of digestive cancer. This technology helps doctors operate more accurately, limit invasion, reduce blood loss and support patients to recover quickly after surgery.
According to Mr. Ryan Johnston - Asia Regional Director of Device Technologies Group, the speed of development of robot-assisted surgery in Vietnam is attracting attention in the region thanks to the increasing investment of hospitals and the professional capacity of the team of doctors. Meanwhile, the cost of robot-assisted treatment in Vietnam is still more competitive than in Thailand or Singapore, opening up opportunities for more patients to access advanced treatment technology right in the country.
